SCHEMBL4769815

SCHEMBL4769815

CCOC(O)(c1ccccc1)C(C)(N)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.47
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
HTT P42858 1/20 0.37
CYP2D6 P10635 3/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.36
KCNN4 O15554 2/20 0.36
CHRM2 P08172 2/20 0.35
CHRM1 P11229 2/20 0.35
CHRM3 P20309 2/20 0.35
LMNA P02545 2/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
KCNH2 Q12809 1/20 0.35
SCN5A Q14524 3/20 0.35
SCN9A Q15858 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8938100 0.78 MAPT (0.50) KMT2AMAPTSMN1; SMN2CYP2C19HIF1A
SCHEMBL21644502 0.77 KMT2A (0.48) KMT2AMAPTSMN1; SMN2POLBCYP2C19
SCHEMBL4561507 0.75 CYP2D6 (0.50) KMT2AMAPTCYP2C19HIF1AHTT
SCHEMBL28780291 0.74 SMN1; SMN2 (0.40) KMT2ASMN1; SMN2POLBCYP2C19HIF1A
SCHEMBL27845934 0.72 KCNN4 (0.41) KMT2AMAPTSMN1; SMN2POLBCYP2C19
SCHEMBL28288133 0.71 SMN1; SMN2 (0.38) KMT2ASMN1; SMN2POLBCYP2C19HTT
SCHEMBL8573483 0.71 ALDH1A1 (0.39) KMT2AMAPTSMN1; SMN2POLBCYP2C19
SCHEMBL28859615 0.70 CYP2C19 (0.47) KMT2AMAPTSMN1; SMN2POLBCYP2C19
SCHEMBL3685988 0.70 TAAR1 (0.45) KMT2AMAPTSMN1; SMN2CYP2C19HIF1A
SCHEMBL1357103 0.70 ALDH1A1 (0.45) KMT2AMAPTSMN1; SMN2POLBCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1981837-A2 METHODS AND COMPOSITIONS FOR MODULATING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ACTIVITY Praecis Pharmaceuticals Incorporated (US) 2008-10-22 EP disclosed
WO-2007092190-A2 METHODS AND COMPOSITIONS FOR MODULATING SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR ACTIVITY PRAECIS PHARMACEUTICALS, INC. (US) 2007-08-16 WO disclosed